Teenagers Turn to Cancer Drug for Heightmaxxing Amid Safety Concerns

In 2026, a troubling trend known as 'heightmaxxing' has emerged among teenagers, where some are resorting to taking erdafitinib, a prescription drug originally designed to treat certain cancers, in hopes of gaining height. This phenomenon reflects a broader societal obsession with physical appearance, particularly among young people who feel pressured to conform to idealized body standards. According to recent reports, teenagers are purchasing this medication online, often without medical supervision, and sharing their experiences on social media platforms.

Erdafitinib, marketed under the brand name Balversa, was approved in the United States in 2019 for treating advanced urothelial cancer. However, its use for height enhancement is neither approved nor supported by scientific evidence. The trend has gained traction due to anecdotal reports of unexpected growth in children who received the drug during cancer treatment.

One notable case is that of Zak, a 17-year-old TikTok user from New York, who began taking erdafitinib at the age of 15. He reported purchasing the drug from overseas sellers, initially spending around $300 for a month's supply. Zak's decision was influenced by social media discussions about height and dating, as well as personal experiences of being teased for his height. He has since experienced side effects, including severe joint pain and nosebleeds, yet he remains convinced of the benefits he perceived from the drug.

The medical community has expressed serious concerns regarding the use of erdafitinib for height enhancement. Experts like Adalbert Raimann, a pediatric endocrinologist, warn that the long-term effects of using this drug in healthy adolescents are unknown. Erdafitinib works by blocking fibroblast growth factor receptors (FGFRs), which are crucial in regulating bone growth. Interfering with these processes could lead to unforeseen complications in healthy individuals.

Andrew Dauber, another pediatric endocrinologist, categorically states that he would not prescribe erdafitinib for height increase, labeling the practice as dangerous. The lack of clinical trials or substantial research supporting the safety and efficacy of erdafitinib for this purpose raises ethical questions about the responsibility of healthcare providers and the influence of social media on youth behavior.

The rise of heightmaxxing can be attributed to the pervasive influence of social media, where platforms like TikTok and Instagram amplify discussions around physical appearance. Users often share tips and personal stories, creating a community that normalizes risky behaviors in pursuit of an idealized self-image. The pressure to conform to societal standards of attractiveness can lead to detrimental choices, as seen in Zak's case.

The trend is part of a larger 'maxxing' culture, where young people engage in various practices to enhance their looks, including 'looksmaxxing,' which focuses on improving facial features and physique. This culture thrives on the validation received through likes and shares, further perpetuating the cycle of insecurity and unhealthy behaviors.

The self-medication trend among teenagers raises significant public health concerns. Many adolescents are acquiring erdafitinib without prescriptions, often from unregulated online sources. This not only poses risks associated with the drug itself but also highlights the lack of oversight in the sale of prescription medications online.

The potential for misuse and the absence of medical guidance can lead to severe health consequences, including adverse reactions and long-term health issues. The case of Zak, who has already experienced side effects, serves as a cautionary tale about the dangers of using prescription drugs outside their intended purpose.

As the heightmaxxing trend continues to grow, it is crucial for parents, educators, and healthcare professionals to engage in open conversations with teenagers about body image and the risks associated with self-medication. Raising awareness about the dangers of using unapproved medications for height enhancement is essential in combating this trend.

Furthermore, regulatory bodies must take action to ensure that prescription medications are not easily accessible without proper medical oversight. The health and well-being of adolescents should be prioritized over fleeting social media trends, emphasizing the importance of informed decisions and responsible health practices.